![](/img/cover-not-exists.png)
P2.04-84 NSCLC Survival Expectancy for Patients Treated with Docetaxel/Nintedanib in the SENECA Trial and Previous Immunotherapy
Capelletto, E., Osman, G., Morabito, A., Chiari, R., Grossi, F., Tiseo, M., Di Costanzo, F., Delmonte, A., Romano, G., Misino, A., Scotti, V., Gregorc, V., Pisconti, S., Bonomi, M., Del Conte, A., CiuVolume:
14
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.08.1589
Date:
October, 2019
File:
PDF, 219 KB
english, 2019